Clinical Trial Update: A 24-week rPMS Study in Real-world Setting for Enerzair

View source ↗

Summary

This entry describes a 24-week real-world study of Enerzair for asthma, sponsored by Novartis, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Enerzair

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Asthma | Status: RECRUITING